Currently out of the existing stock ratings of James Quigley, 28 are a HOLD (68.29%), 11 are a BUY (26.83%), 2 are a SELL (4.88%).

James Quigley

Work Performance Price Targets & Ratings Chart

Analyst James Quigley works at MORGAN STANLEY with a stock forecast success ratio of 58.21% fulfilled within 184.5 days on average.

James Quigley’s has documented 75 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GLPG, Galapagos NV ADR at 07-Mar-2024.

Wall Street Analyst James Quigley

Analyst best performing recommendations are on KYMR (KYMERA THERAPEUTICS).
The best stock recommendation documented was for KYMR (KYMERA THERAPEUTICS) at 11/13/2023. The price target of $24 was fulfilled within 30 days with a profit of $9.02 (60.21%) receiving and performance score of 20.07.

Average potential price target upside

MOR MorphoSys AG ADR GLPG Galapagos NV ADR EVO Evotec SE ADR KYMR Kymera Therapeutics

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

17

$-1.15 (-6.34%)

17

2 months 15 days ago

3/3 (100%)

$-0.27 (-1.56%)

96

Hold

9.2

3 months 4 days ago

4/10 (40%)

$2.7 (41.54%)

490

Buy

8.5

$-9.65 (-53.17%)

10

4 months 15 days ago

2/7 (28.57%)

$0.92 (12.14%)

106

Buy

8.5

$-9.65 (-53.17%)

10

4 months 15 days ago

2/2 (100%)

$0.92 (12.14%)

106

Hold

4.75

$-13.1 (-73.39%)

4 months 29 days ago

1/2 (50%)

$0.2 (4.40%)

5

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is James Quigley is most bullish on?

Potential upside of $6.14 has been obtained for GLPG (GALAPAGOS NV ADR)

Which stock is James Quigley is most reserved on?

Potential downside of -$12.37 has been obtained for KYMR (KYMERA THERAPEUTICS)

What Year was the first public recommendation made by James Quigley?

On 2018

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?